Julian Manuel Michael Rogasch (Julian M Rogasch, Julian Rogasch, Julian M M Rogasch)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Liver Metastases

Positron Emission Tomography

Top Venues

Diagnostics (Basel, Switzerland)

Clinical nuclear medicine

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Julian Manuel Michael Rogasch, Hans V Jochens, Giulia Metzger, Christoph Wetz, Jonas Kaufmann, Christian Furth, Holger Amthauer, Imke Schatka
Keeping Up With ChatGPT: Evaluating Its Recognition and Interpretation of Nuclear Medicine Images. Clinical nuclear medicine (2024)
Julian Manuel Michael Rogasch, Hans V Jochens, Giulia Metzger, Christoph Wetz, Jonas Kaufmann, Christian Furth, Holger Amthauer, Imke Schatka
Keeping Up With ChatGPT: Evaluating Its Recognition and Interpretation of Nuclear Medicine Images. Clinical nuclear medicine 49 (6) (2024)
Julian Manuel Michael Rogasch, Liza Michaels, Georg L Baumgärtner, Nikolaj Frost, Jens-Carsten Rückert, Jens Neudecker, Sebastian Ochsenreither, Manuela Gerhold, Bernd Schmidt, Paul Schneider, Holger Amthauer, Christian Furth, Tobias Penzkofer
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [ 18 F]FDG-PET/CT parameters. European journal of nuclear medicine and molecular imaging (2023)
Sebastian Gaal, Kai Huang, Julian Manuel Michael Rogasch, Hans V Jochens, Maria De Santis, Barbara Erber, Holger Amthauer
Prognostic Value of the De Ritis Ratio for Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [ 177 Lu]Lu-PSMA-617 Radioligand Therapy. Cancers 15 (20) (2023)
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, Jane Grabowski, Henning Jann, Giulia Metzger, Markus Galler, Holger Amthauer, Julian Manuel Michael Rogasch
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy. Cancers 15 (24) (2023)
Julian Manuel Michael Rogasch, Kuangyu Shi, David Kersting, Robert Seifert
Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET). Nuklearmedizin. Nuclear medicine 62 (6) (2023)
Jeffrey Siefert, Jonas Kaufmann, Felix Thiele, Thula Cannon Walter-Rittel, Julian Manuel Michael Rogasch, Robert Biesen, Gerd R Burmester, Holger Amthauer, Udo Schneider, Christian Furth
Performance of Deauville Criteria in [18F] FDG-PET/CT Diagnostics of Giant Cell Arteritis. Diagnostics (Basel, Switzerland) 13 (1) (2023)
Jeffrey Siefert, Jonas Kaufmann, Felix Thiele, Thula Cannon Walter-Rittel, Julian Manuel Michael Rogasch, Robert Biesen, Gerd R Burmester, Holger Amthauer, Udo Schneider, Christian Furth
Performance of Deauville Criteria in [18F] FDG-PET/CT Diagnostics of Giant Cell Arteritis. Diagnostics (Basel, Switzerland) 13 (1) (2023)
Jeffrey Siefert, Jonas Kaufmann, Felix Thiele, Thula Cannon Walter-Rittel, Julian Manuel Michael Rogasch, Robert Biesen, Gerd R Burmester, Holger Amthauer, Udo Schneider, Christian Furth
Performance of Deauville Criteria in [18F] FDG-PET/CT Diagnostics of Giant Cell Arteritis. Diagnostics (Basel, Switzerland) 13 (1) (2023)
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, Jane Grabowski, Henning Jann, Giulia Metzger, Markus Galler, Holger Amthauer, Julian Manuel Michael Rogasch
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy. Cancers 15 (24) (2023)
Laura Jacqueline Jensen, Julian Manuel Michael Rogasch, Damon Kim, Juliana Rießelmann, Christian Furth, Holger Amthauer, Bernd Hamm, Ingo G Steffen, Thomas Elgeti, Sebastian N Nagel
CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations. Scientific reports 12 (1) (2022)
Markus Galler, Julian Manuel Michael Rogasch, Kai Huang, Henning Jann, Kristina Plehm, Christoph Wetz, Holger Amthauer
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [ 177 Lu]Lu-DOTATOC. Cancers 14 (7) (2022)
Imke Schatka, Hans V Jochens, Julian Manuel Michael Rogasch, Thula Cannon Walter-Rittel, Uwe Pelzer, Julia Benckert, Josefine Graef, Felix W Feldhaus, Bernhard Gebauer, Holger Amthauer
Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score. Cancers 14 (21) (2022)
Julian Manuel Michael Rogasch, Frank Hofheinz, Lutz van Heek, Conrad-Amadeus Voltin, Ronald Boellaard, Carsten Kobe
Influences on PET Quantification and Interpretation. Diagnostics (Basel, Switzerland) 12 (2) (2022)
Tristan Ruhwedel, Julian Manuel Michael Rogasch, Kai Huang, Henning Jann, Imke Schatka, Christian Furth, Holger Amthauer, Christoph Wetz
The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [177Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis. Cancers 13 (4) (2021)
Imke Schatka, Monique Tschernig, Julian Manuel Michael Rogasch, Stephanie Bluemel, Josefine Graef, Christian Furth, Jalid Sehouli, Jens-Uwe Blohmer, Bernhard Gebauer, Fehrenbach Uli, Holger Amthauer
Selective Internal Radiation Therapy in Breast Cancer Liver Metastases: Outcome Assessment Applying a Prognostic Score. Cancers 13 (15) (2021)
Julian Manuel Michael Rogasch, Said Suleiman, Frank Hofheinz, Stephanie Bluemel, Mathias Lukas, Holger Amthauer, Christian Furth
Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF). EJNMMI physics 7 (1) (2020)
Julian Manuel Michael Rogasch, Christian Furth, Stephanie Bluemel, Piotr Radojewski, Holger Amthauer, Frank Hofheinz
Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies. EJNMMI research 10 (1) (2020)
Julian Manuel Michael Rogasch, Patrick Hundsdoerfer, Christian Furth, Florian Wedel, Frank Hofheinz, Paul-Christian Krüger, Holger Lode, Winfried Brenner, Angelika Eggert, Holger Amthauer, Imke Schatka
Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome? European journal of nuclear medicine and molecular imaging 44 (13) (2017)